The European Medicines Agency (EMA) has approved the use of a coronavirus vaccine developed by the American Pfizer and the German BioNTech across the European Union. It was reported by DW.
The EU drug regulator said it was recommending the shot be given to people over 16 years of age.
“It’s a decisive moment in our efforts to deliver safe & effective vaccines to Europeans," Commission President Ursula von der Leyen tweeted shortly after the announcement.
“Now we will act fast,” she said, adding that she expected that the Commission’s formal approval could be signed off by the evening — quicker than the already accelerated two days that had been expected.
Authorities in Germany and several other European countries have said they hope to begin giving the vaccine to people on Dec. 27.
As we reported earlier, Health Minister of Germany Jens Spahn stated that Pfizer/BioNTech vaccine would be effective against new coronavirus strain.
Jens Spahn reported that considering all information possessed by his ministry, the new strain does not influence vaccine and it will remain equally effective.
